1. Natural killer cell activity and monocyte cyto toxicity was evaluated in three subgroups of patients with primary hypogammaglobulinaemia (ten patients with lateonset. eight with X-linked and five with early-onset disease) and in two patients with secondary late-onset hypogammaglobulinaemia against the K-562 erythroleukaemia, the CaCo-2 colon carcinoma and the HGT-1 gastric carcinoma cell lines and com pared with the results found in healthy control subjects.
INTRODUCTION
Primary hypogammaglobulinaemia, especially in its lateonset form, is associated with impairments of not only humoral but also of cellular immune responses [1, 2] . Several studies indicated that these patients have an increased incidence of malignancies; in particular, patients with late-onset hypogammaglobulinaemia have an increased chance of developing non-Hodgkin lymphoma and a 50-fold increased chance of developing stomach cancer [3] [4] [5] . Natural killer (NK) cells are part of the natural immune system and play a role in the resist ance against virus-infected cells and tum our cells [6] . Studies on NK cell activity in primary immunodeficien cies have been scarce and inconclusive, i.e. both normal and incidentically decreased NK cell activity have been found. However, a majority of the studies indicate that within the group of patients with common variable hypo gammaglobulinaemia some patients show decreased NK cell activity, but in this regard no subpopulations of patients could be defined (Table 1 [7] [8] [9] [10] [11] [12] [13] ).
In the present study w'e measured the NK cell activity and monocyte cytotoxicity in well-defined subgroups of patients with primary hypogammaglobulinaemia. Cyto toxicity, both spontaneous and after stimulation with recombinant y-interferon and the lectin phytohaem agglutinin (PHA), was determined against lymphoid and gastrointestinal cell lines.
MATERIALS AND M ETHODS

Patients and control subjects
Twenty-three patients with primary hypogamma globulinaemia were studied. Ten patients with late-onset hypogammaglobulinaemia (four females and six males. Abbreviations: CVH, common variable hypogammaglobulinaemia; IgA def, selective IgA  deficiency; XLA, X-linked agammaglobulinaemia; CVA, common variable agammaglobulinaemia; CVI, common variable immunodeficiency; SCID, severe combined immunodeficiency; Ig, immunoglobulin.
Table 1. NK cells in hypogammaglobulinacniia
Reference Immunodeficiency (no. of patients) NK cell observation Sirianni et al. [7] Koren et al. [S] Messina et al. [9] Gupta [10] Lipinski et al. [Il] Peter et al. [12] Clerici et al. [13] IüA def ( 10) . CVH (5) The criteria used for the diagnosis of primary hypo gammaglobulinaemia were for X-linked hypogamma globulinaemia the onset of clinical signs during the first 2 years of life, a family history compatible with an X-linked pattern of inheritance, and absence or profound decrease of B-lymphocytes in the peripheral blood or bone marrow. In patients in whom clinical symptoms began before the age of 2 years but no evidence for X-linked inheritance was found, the diagnosis of early-onset hypo gammaglobulinaemia was made. In these patients, B-lymphocytes were either absent, scarce or present in normal numbers. Patients were considered to have lateonset hypogammaglobulinaemia if clinical manifestations began after the age of 10 years and B-lymphocytes, but not plasma cells, were found in the bone marrow [1, 2] .
The control subjects consisted of 25 healthy volunteers (nine females and 16 males, mean age 36 years, range 2 2 -5 8 years), none of whom had signs of immuno deficiency or recurrent infection.
Peripheral blood mononuclear cells
M ononuclear cells were obtained by Ficoll-H ypaque density gradient centrifugation of heparinized peripheral blood. Part of the total mononuclear ccll suspension was used in the cytotoxicity assay without further purification, while the other part was separated in lymphocytes and monocytes by élutriation centrifugation by a previously described technique [ 13] . The viability of these fractions, determined by Trypan Blue exclusion, was more than 98%. The fractions were kept in RPM1 1640 medium supplemented with 2 mM-glutamine, penicillin ( 100 units/ ml), streptomycin (100 //g/ml), gentamycin (50 /¿g/ml), amphotericin B (2.5 /¿g/ml) and 10% (v/v) fetal calf serum. T he composition and purity of the ccll fractions were evaluated by cell identification on cytospins with a May-Griinwald/Giemsa stain and non-specific esterase staining for monocytes in the cell suspensions. T he purity of the lymphocyte fraction was usually above 98%, whereas for monocytes this was found to be greater than 80%. Monocyte purity was further increased to above 95% by 90 min adherence in 96-well culture plates and removal of the non-adhered cells by three washings with culture medium.
Cytotoxicity assay
T he cytotoxicity assay was performed as previously described [ 14|. Effector cells, i.e. total mononuclear cells, and separated lymphocytes and monocytes were cultured for 24 h at 37°C in a 5% C O :/95% air mixture in culture medium to reverse any possible adverse effects of the isolation process before functional assay. T he target cells used were the erythroleukaemia cell line K-562, the human colon cancer cell line CaCo-2 and the human gastric carcinoma cell line HGT-1 [15] . T he K-562 and HGT-1 cell lines were cultured in RPMI 1640 medium supplemented with 10% (v/v) fetal calf serum, CaCo-2 with 20% (v/v) fetal calf serum and antibiotics, and were kept in growth phase by transferring 1:3 twice a week. The target cells were harvested and labelled with N a2MCrO^ (100 /¿C i/5x 1()() cells; NEN Dupont, West Germany) for 1 h at 37°C. T he effector to target ratio used for all populations was 50:1; for the monocytes the number of plating cells was adjusted to the 2.5 x 106/ml non-specific esterase positive cells. Recombinant y-inter feron (ry-IFN; Boehringer, Ingelheim, West Germany) and PHA (Wellcome Research, Beckenham, Kent, U.K.) were dissolved in culture medium. The assay concentra tion for ry-IFN was 500 units/ml added at the start of the 24 h preincubation period. The concentration of PHA was 1 /¿g/ml. The assay was performed in triplicate with a final volume of 200 //1/well. After the target cells were added, the plates were centrifuged for 5 min at 500 # an d incubated for 18 h at 37°C in a 5% C O :/95% air atm o sphere. After 18 h incubation the supernatant was collected by a harvesting system (Supernatant Collection System; Skatron AS, Licr, Norway). T he released label was counted in a y-counter. T he spontaneous release was determined by incubation of the target cells with culture medium, ry-IFN or PHA and the maximal release by incubation of the targets with saponin. Cellular cyto toxicity was calculated by using the following formula: Cytotoxicity (%) = experimental release -spontaneous release maximal release -spontaneous release x 100
The cytotoxicity assay for all cell populations, i.e. total mononuclear cells and the enriched lymphocytes and monocytes, was for uniformity performed as an 18 h assay. T he specificity of the 18 h cytotoxicity assay for NK cells was determined by complement lysis of Leu 1 1 (CD 16) monoclonal antibody coated mononuclear cells in four experiments. Inhibition of the 18 h cytotoxicity was above 85% both for K-562 and for CaCo-2.
Statistical analysis
All data are expressed as means ± sem. The statistical significances of the differences were evaluated with the non-parametric two-tailed Wilcoxon's rank-sum and the /-'-Fisher's exact tests.
RESULTS
The spontaneous NK cell activity showed a tendency to be decreased in the total group of patients with primary hypogammaglobulinaemia only against the K-562 targets (/,= 0.056). When divided into subgroups, only patients with late-onset hypogammaglobulinaemia were found to have a significantly impaired NK cell activity (P< 0.05) against the K-562 targets; the NK cell activity against the CaCo-2 and HGT-1 was similarly impaired, although the differences failed to reach statistical significance ( Table 2) . When 50% cytotoxicity was used as the lower limit of normal, 60% of the patients with late-onset hypogamma globulinaemia (six out of ten) were found to have low levels of NK cell activity (P< 0.05), whereas in X-linked (four out of eight; 50%), in early-onset (one out of five; 20%) and in secondary late-onset hypogammaglobulin aemia (none out of two; 0%) NK cell activity was not sig nificantly different when compared with the control subjects (one out of 19; 5%) ( Fig. 1) . No differences were found in any of the clinical parameters (age, sex, duration of illness and treatments) between patients with decreased NK cell activity and those without.
Lectin-mediated cytotoxicity by PHA resulted in a significant increase in the cytotoxicity of the total m ono nuclear cells of all patients and control subjects (all groups P< 0.05), irrespective of the underlying disease or the target cell line used, towards a maximal cytotoxicitv level of 75-80% .
ry-IFN also stimulated the NK cell activity sub stantially (all groups /><0.05). However, this stimulation did not overcome the deficient spontaneous cytotoxicity found in the patients with late-onset hypogammaglobulin aemia ( Table 2) .
Studies with the enriched lymphocytes from patients and control subjects, obtained by élutriation centrifuga tion, showed a similar pattern in the spontaneous and stimulated cytotoxicity revealing a lower NK cell response in patients with late-onset hypogammaglobulinaemia (data not shown).
Purified monocytes, both from patients and control subjects, hardly showed any spontaneous cytotoxic activity against each of the cell lines used. Stimulation Table 2 with ry-IFN increased the monocyte-mediated cyto toxicity significantly (all groups P<0X)5) with no dif ferences between patients, subgroups or patients and control subjects, nor between the three target cell lines used (Table 3) .
. NK cell activity, spontaneous and after stimulation with ry-IFN, of total mononuclear cells from patients with hypogammaglobulinaemia and control subjects
Table 3. Spontaneous and ry-IFN-stinmlated cytotoxicity of peripheral blood monocytes from patients with hvpogamniaglobulinaeniia and control subjects against K-562 targets
DISCUSSION
In the present study we evaluated the NK cell activity in patients with primary hypogammaglobulinaemia. Patients with late-onset hypogammaglobulinaemia were found to have a significant decreased NK cell activity, both spon taneous and after stimulation with ry-IFN, whereas such an impairment was less prominent in patients with other forms of primary hypogammaglobulinaemia and absent in second a ry h y pogam m agio bu 1 i nae m i a.
Previous reports on NK cell activity in primary hypo gammaglobulinaemia were not conclusive with regard to disease-related differences. Some studies describe a normal NK cell activity |7, 8], whereas others show decreased NK cell activity or NK cell numbers in hypo gammaglobulinaemia patients without the identification of subgroups of patients [9] [10] [11] [12] [13] . In our study we also found a normal NK cell activity in the total group of patients with primary hypogammaglobulinaemia. Remarkably, however, both Gupta 110) and Lipinski ct nl. 1 11 found that in the subgroup of late-onset hypogamma globulinaemia patients NK cell numbers or activity were low (respectively three out of eight, and two out of four patients). We found similar numbers of patients with decreased NK cell activity in the subgroup of patients with late-onset hypogammaglobulinaemia (six out of ten patients). In the patients with other forms of hypogamma globulinaemia, a decrease in NK cell activity was found less frequently in our study, which corresponds with previous reports [7, 8] . However, the number of patients studied were small which limited statistical analysis of the « / frequency of this phenom enon in these subgroups. The decrease in NK cell activity of late-onset hypogamma globulinaemia patients in our study was not target
specific, since it was noticed against the standard NK cell line K-562 but also against the colorectal cancer CaCo-2 C T and the gastric cancer HGT-1 cell lines. This is especially interesting since patients with late-onset hypogamma globulinaemia have an increased incidence of non-Hodgkin lymphoma and gastric cancer |3, 4|. Thus, the decreased NK cell activity may identify late-onset hypo gammaglobulinaemia as a pre-malignant condition. Inter estingly, a completely different study by our group on the gastrin response to bombesin stimulation in primary hypogammaglobulinaemia, also identified the late-onset hypogammaglobulinaemia patients as a high cancer risk subgroup 116]. Prospective and follow-up studies need to be performed to determine whether the susceptibility for malignancy is especially increased in the patients with reduced NK cell activity and reduced plasma gastrin response to bombesin stimulation.
We found a normal response of the NK cells to ry-IFN which did not overcome the decreased spontaneous NK cell activity in the patients with late-onset hypogamma globulinaemia. These findings correspond to previous reports in which both the production of and the response to interferon in hypogammaglobulinaemia patients was found to be normal |9. 1 11 .
Hypogammaglobulinaemia patients showed a normal lectin-mediated cytotoxicity with no difference between • > J the subgroups. There is only one other study, by Lubens ct til. 117), which showed that two patients with hypo gammaglobulinaemia also had a normal PHA-induced cytotoxic response, therefore indicating that the synthesis of interleukin-2 and its receptor, which is mediated by PHA. is fully intact in patients with primary hypoga m m agio b u 1 i n ae m i a.
Monocytes, known to have cytotoxic capabilities 118 showed a normal spontaneous and ry-IFN-induced cyto toxicity in patients with primary hypogammaglobulin-Cytotoxicity in hypogammaglohulinaemia 137 acmia which indicates that they do not contribute to the deficient cytotoxic response of patients with late-onset hypogammaglobulinaemia.
In conclusion, a majority of patients with late-onset hypogammaglobulinaemia have an impaired NK cell activity against several tum our cell lines. Stimulation with ry-IFN and PH A results in a normal response in these patients. O ther forms of primary hypogammaglobulin aemia have a lower frequency of the impairment of NK cell activity. The relevance of these findings with regard to the high incidence of gastric cancer in late-onset hypo gammaglobulinaemia has yet to be established.
